NEPH vs FELE

For growth investors, Nephros, Inc.

(NEPH) is the stronger pick with 32. 7% revenue growth year-over-year, versus 5. 4% for Franklin Electric Co. , Inc. (FELE). Nephros, Inc. (NEPH) offers the better valuation at 29. 4x trailing P/E, making it the more compelling value choice. Analysts rate Franklin Electric Co. , Inc. (FELE) a "Hold" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Nephros, Inc.

(NEPH) is the cheapest at 29. 4x versus Franklin Electric Co. , Inc. at 30. 8x.

Over the past 5 years, Franklin Electric Co.

, Inc. (FELE) delivered a total return of +20. 3%, compared to -56. 3% for Nephros, Inc. (NEPH). Over 10 years, the gap is even starker: FELE returned +229. 5% versus NEPH's +11. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Nephros, Inc.

(NEPH) is the lower-risk stock at 0. 58β versus Franklin Electric Co. , Inc. 's 0. 89β — meaning FELE is approximately 54% more volatile than NEPH relative to the S&P 500. On balance sheet safety, Nephros, Inc. (NEPH) carries a lower debt/equity ratio of 10% versus 21% for Franklin Electric Co. , Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Nephros, Inc.

(NEPH) is pulling ahead at 32. 7% versus 5. 4% for Franklin Electric Co. , Inc. (FELE). Over a 3-year CAGR, NEPH leads at 23. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Franklin Electric Co.

, Inc. (FELE) is the more profitable company, earning 6. 9% net margin versus 6. 4% for Nephros, Inc. — meaning it keeps 6. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FELE leads at 12. 7% versus 6. 1% for NEPH. At the gross margin level — before operating expenses — NEPH leads at 61. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, FELE (1.

1% yield) pays a dividend. NEPH does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Franklin Electric Co.

, Inc. (FELE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 89), 1. 1% yield, +229. 5% 10Y return). Both have compounded well over 10 years (FELE: +229. 5%, NEPH: +11. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (NEPH (Healthcare) and FELE (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: NEPH is a small-cap high-growth stock; FELE is a small-cap quality compounder stock. FELE pays a dividend while NEPH does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.